ResearchPad - meeting-report https://www.researchpad.co Default RSS Feed en-us © 2020 Newgen KnowledgeWorks <![CDATA[Steering the Clinical Translation of Delivery Systems for Drugs and Health Products]]> https://www.researchpad.co/article/elastic_article_11929 Besides the feasibility for industrial scale-up, accelerating the translation from bench to bedside of new technological strategies for controlled delivery and targeting of drugs and other actives relevant for health management, such as medical devices and nutraceuticals, would benefit from an even earlier evaluation in pre-clinical models and clinical settings. At the same time, translational medicine also performs in the opposite direction, incorporating clinical needs and observations into scientific hypotheses and innovative technological proposals. With these aims, the sessions proposed for the 2019 CRS Italy Chapter Workshop will introduce the experience of Italian and worldwide researchers on how to foster the actual work in controlled release and drug delivery towards a reliable pre-clinical and clinical assessment.

]]>
<![CDATA[2009年北京胸外科学术年会隆重召开]]> https://www.researchpad.co/article/5c052cb5d5eed0c4848a89fa <![CDATA[《肺癌骨转移诊疗专家共识》审稿会会议纪要]]> https://www.researchpad.co/article/5c052c78d5eed0c4848a8273 <![CDATA[中国控制吸烟协会吸烟与疾病控制专业委员会成立大会纪要及倡议书]]> https://www.researchpad.co/article/5c052ba0d5eed0c4848a68bc <![CDATA[“首届国际呼吸内镜诊治大会暨肺癌诊疗新技术新进展学习班”会议纪要]]> https://www.researchpad.co/article/5c052b46d5eed0c4848a5c5e <![CDATA[11th Tuscany Retreat on Cancer Research and Apoptosis: Genetic profiling, resistance mechanisms and novel treatment concepts in cancer and neurodegeneration]]> https://www.researchpad.co/article/Nf32e69cf-7a75-4af0-962f-416289cb7bf9 <![CDATA[6th International Multithematic Scientific Bio-Medical Congress (IMBMC), Nicosia, Cyprus, 2018]]> https://www.researchpad.co/article/N4cd59278-d43d-4358-bad5-88f2329d41f4 <![CDATA[Viral pathogenesis and immune control]]> https://www.researchpad.co/article/N2ffb4468-324f-442a-a4c0-748f662fb04d ]]> <![CDATA[Building a bioelectronic medicine movement 2019: insights from leaders in industry, academia, and research]]> https://www.researchpad.co/article/N289af087-e271-4b55-b707-4097fe8476d8

In April 2019, a select group of medical, academic, and private-sector leaders in bioelectronic medicine convened in Geneva to discuss the potential for building a cross-disciplinary movement that would advance the field with key stakeholders – both those who are already active in research and commercialization as well as those who will influence the pace of development and uptake of innovative technologies and treatments. Hosted by BioSig Technologies and physicians from the Mayo Clinic, the roundtable was unique in its focus on what it will take to advance awareness of bioelectronic medicine, including a shared definition, unified narrative, and set of tailored messages to win over key audiences. The attendees developed a consensus on these issues and agreed to form a working group beyond the roundtable, which has since evolved into the Alliance for Advancing Bioelectronic Medicine. This meeting report summarizes the key insights from the roundtable, including a call to action aimed at accelerating growth and collaboration across the field.

]]>
<![CDATA[Cleveland neural engineering workshop 2017: strategic evaluation of neural engineering]]> https://www.researchpad.co/article/N9806f6ab-37bd-4b5e-b322-aaa64e11a37b

The Cleveland Neural Engineering Workshop (NEW) was established as a biennial meeting in 2011, with subsequent meetings taking place in 2013, 2015, and most recently, June 2017. This fourth biennial NEW was hosted by the Cleveland Advanced Platform for Technology National Veterans Affairs Center, the Functional Electrical Stimulation National Veterans Affairs Center, the Biomedical Engineering Department at Case Western Reserve University in Cleveland, Ohio, and Northwell Health’s Feinstein Institute for Medical Research of New York. The workshop connects leaders and stakeholders in the neural engineering community who are devoted to developing and deploying technological solutions to those with neurological disorders. The meeting in 2017 continued strategic conversations initiated at the third Cleveland NEW conference in 2015. The goal of the 2017 workshop was to was to determine specific actions by which the neural engineering community might advance the goals outlined in 2015, assess progress towards that plan, adjust as necessary, and establish continued strategic direction. This meeting report summarizes the outcomes.

]]>
<![CDATA[Recent Advances in Systems and Network Medicine: Meeting Report from the First International Conference in Systems and Network Medicine]]> https://www.researchpad.co/article/Nfb874930-4d50-4063-98f5-7f1ca6f4e5f1

The First International Conference in Systems and Network Medicine gathered together 200 global thought leaders, scientists, clinicians, academicians, industry and government experts, medical and graduate students, postdoctoral scholars and policymakers. Held at Georgetown University Conference Center in Washington D.C. on September 11–13, 2019, the event featured a day of pre-conference lectures and hands-on bioinformatic computational workshops followed by two days of deep and diverse scientific talks, panel discussions with eminent thought leaders, and scientific poster presentations. Topics ranged from: Systems and Network Medicine in Clinical Practice; the role of -omics technologies in Health Care; the role of Education and Ethics in Clinical Practice, Systems Thinking, and Rare Diseases; and the role of Artificial Intelligence in Medicine. The conference served as a unique nexus for interdisciplinary discovery and dialogue and fostered formation of new insights and possibilities for health care systems advances.

]]>
<![CDATA[Guidelines for a training programme in intensive care medicine]]> https://www.researchpad.co/article/Nb28d6200-8db0-4fa5-96f1-833b46fa39ad ]]> <![CDATA[Transcriptional networking]]> https://www.researchpad.co/article/5b7a50b8463d7e3eb6394869

A report on the European Science Foundation workshop ‘Transcription Networks: A Global View’, Madrid, Spain, 26-28 May 2005.

]]>
<![CDATA[Epigenetic regulation: DNA confers identity but is not enough to maintain it]]> https://www.researchpad.co/article/5b7ac0ad463d7e555deeee69

A report on the conference 'Epigenetics and the dynamic genome', 30 June-2 July 2005, Babraham, Cambridge, UK.

]]>
<![CDATA[Cancer and kinases: reports from the front line]]> https://www.researchpad.co/article/5b7b98dd463d7e6b93cc261c

A report on the Keystone Symposium 'Cancer and Kinases: Lessons from the Clinic', Santa Fe, USA, 14-19 February 2006.

]]>
<![CDATA[Bioinformatics meets systems biology]]> https://www.researchpad.co/article/5b7ac09b463d7e555deeee5a

A report on the Fifth International Workshop on Bioinformatics and Systems Biology, Berlin, Germany, 22-25 August 2005.

]]>
<![CDATA[High society (of nematologists)]]> https://www.researchpad.co/article/5b79e0aa463d7e2219d4cdd0

A report on the 43rd annual meeting of the Society of Nematologists (SON), Estes Park, USA, 7-11 August 2004.

]]>
<![CDATA[The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019]]> https://www.researchpad.co/article/Nd33f38fc-36e6-4f8e-b507-55686b56c585

The Great Debate session at the 2019 Melanoma Bridge congress (December 5-7, Naples, Italy) featured counterpoint views from experts on five topical issues in melanoma. These were whether to choose local intratumoral treatment or systemic treatment, whether patients with stage IIIA melanoma require adjuvant therapy or not, whether treatment is better changed at disease progression or during stable disease, whether adoptive cell transfer (ACT) therapy is more appropriate used before or in combination with checkpoint inhibition therapy, and whether treatment can be stopped while the patient is still on response. As was the case for previous meetings, the debates were assigned by meeting Chairs. As such, positions taken by each of the melanoma experts during the debates may not have reflected their respective personal approach.

]]>
<![CDATA[Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report]]> https://www.researchpad.co/article/N11740b90-d044-4001-b6ef-588d322710d1

Cambodia targets malaria elimination by 2025. Rapid elimination will depend on successfully identifying and clearing malaria foci linked to forests. Expanding and maintaining universal access to early diagnosis and effective treatment remains the key to malaria control and ultimately malaria elimination in the Greater Mekong Subregion (GMS) in the foreseeable future. Mass Drug Administration (MDA) holds some promise in the rapid reduction of Plasmodium falciparum infections, but requires considerable investment of resources and time to mobilize the target communities. Furthermore, the most practical drug regimen for MDA in the GMS—three rounds of DHA/piperaquine—has lost some of its efficacy. Mass screening and treatment benefits asymptomatic P. falciparum carriers by clearing chronic infections, but in its current form holds little promise for malaria elimination. Hopes that “highly sensitive” diagnostic tests would provide substantial advances in screen and treat programmes have been shown to be misplaced. To reduce the burden on P. falciparum and Plasmodium vivax infections in people working in forested areas novel approaches to the use of malaria prophylaxis in forest workers should be explored. During an October 2019 workshop in Phnom Penh researchers and policymakers reviewed evidence of acceptability, feasibility and effectiveness of interventions to target malaria foci and interrupt P. falciparum transmission and discussed operational requirements and conditions for programmatic implementation.

]]>
<![CDATA[International Regensburg Center for Interventional Immunology (RCI) symposium on “Synthetic immunology and environment-adapted redirection of T cells”, 17–18 July, 2019, Regensburg, Germany]]> https://www.researchpad.co/article/Nc95175f0-1b49-4323-8efd-ca639430b617 ]]>